Project Grant R43HL172484
Award Date
9/20/24
Completion Date
8/31/25
Dollars Obligated
$586K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Kentucky, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will evaluate the use of mobile devices to extract vital signs to monitor patients with asthma. The $459,127 award to M5 Enterprise, LLC (doing business as Emedical Sentry) aims to improve the detection and management of asthma attacks through remote patient monitoring. The goal is to enhance telehealth by incorporating video-based vital sign...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Steth X Microsystems Inc. to develop a smart, wearable contact microphone patch for extended and remote monitoring of lung functions. The goal is to create a low-profile, battery-powered wireless device capable of accurately detecting and quantifying adventitious lung sounds as well as breathing abnormalities in patients with respiratory...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $639,165 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Washington University to develop an equitable and accessible wearable device for continuous calculation of blood loss for postpartum hemorrhage (PPH). The goal is to create a non-invasive sensor that can accurately monitor cardiovascular parameters and estimate blood loss, even with medical...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $295,895 to Ricovr Healthcare Inc. to develop a rapid, low-cost, point-of-care (POC) diagnostic platform for quantitative measurement of placental growth factor (PlGF) to predict and detect pre-eclampsia. The goal is to create an objective, affordable POC tool to improve the clinical diagnosis and monitoring of pre-eclampsia, which...
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support the development of a telemedicine intervention to improve hypertension management for Black patients. The $156,576 award, with a period of performance from September 1, 2024 to August 31, 2029, will be used by the prime awardee, Wake Forest University Health Sciences, to tailor a telemedicine-based hypertension management...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,153 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Safebeat RX Inc. The funding supports the development of a novel, smartwatch-enabled technology that allows patients with low-risk atrial fibrillation to safely initiate antiarrhythmic medications at home. The technology analyzes post-drug ECG data taken by patients using a machine learning algorithm and provides this information to...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $400,000 Project Grant to Electronic Biosciences, Inc. on Sep 20, 2024. The grant supports the development of an innovative analytical testing device to quantitatively characterize lipoprotein particles in blood. This technology will enable rapid, precise, and cost-effective measurement of lipoprotein size, concentration, and other physical properties, which are...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $371,021 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Makani Science Inc., a minority-owned small business located in Irvine, California. The grant aims to develop an accurate and continuous monitoring platform to better characterize and classify apnea of prematurity (AOP) in premature newborns. The 24-month project will involve developing a multimodal hardware and software prototype,...
This National Institutes of Health (NIH) R21/R33 grant award in the amount of $734,360 aims to develop and validate an innovative, inexpensive multi-modal digital stethoscope capable of automated lung sound and respiratory rate analysis, with mobile phone interoperability to an electronic health (eHealth) platform for real-time lower respiratory infection (LRI) and antibiotic surveillance in low- and middle-income countries (LMICs). The grant, awarded under the NIH's Child Health and Human...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,052,276 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Lasarrus Clinic And Research Center Inc. The funding supports a 2-phase SBIR Fast-Track project to develop and validate a wearable multimodal sensor system for remote monitoring of chronic obstructive pulmonary disease (COPD) patients. The project aims to extend the awardee's patented "WearMe" platform to capture bilateral...